Vulvodynia Clinical Trials 2023

What are the top hospitals conducting vulvodynia research?

In the realm of vulvodynia clinical trials, several hospitals and research centers are making remarkable strides in understanding and treating this often misunderstood condition. One such institution is the Sexual Health Research Laboratory at Queen's University in Kingston, Ontario. Although they currently have only one active trial for vulvodynia, their commitment to research is evident as they recorded their first-ever trial on this topic in 2023. Similarly, the Research Center of the Centre Hospitalier Universitaire de Sherbrooke in Sherbrooke, Quebec has also embarked on a groundbreaking journey with one ongoing vulvodynia trial since 2023.

Meanwhile, another hospital within the same city - Centre hospitalier universitaire de Sherbrooke - has shown dedication by conducting two past trials on vulvodynia since initiating their first study back in 2022. This demonstrates a consistent effort towards unraveling the mysteries surrounding this condition. The efforts don't stop there; Exogenia, an institution based in Sherbrooke as well, eagerly joined the quest with their own active trial for vulvodynia beginning in 2022.

Further south lies EvoScient Gynecology located in Virginia Beach. While having only one current vulvodynia clinical trial under its belt so far starting from 2022 onwards it's gaining attention due to its valuable contribution toward tackling this complex condition.

These institutions stand together as beacons of hope for those suffering from vulvodynia and are dedicated to improving our understanding and treatment options for this often overlooked area of women's health concerns. By investing time and resources into clinical trials focused on unravelling these enigmatic symptoms experienced by many individuals affected by Vulvodinia each step taken brings us closer to finding innovative solutions that will transform lives globally

Which are the best cities for vulvodynia clinical trials?

When it comes to vulvodynia clinical trials, several cities are leading the way in research and development. Sherbrooke, Quebec has three active trials focusing on treatments like High Intensity Laser Therapy (HILT) and Real Dry needling. Portland, Oregon follows closely behind with two ongoing studies exploring interventions such as Traditional Vestibulectomy and Mindfulness & Education. Additionally, Kingston, Ontario offers one active trial investigating a 3-month PelvicSense(R) program. Virginia Beach, Virginia also has one active trial examining BioNourish as part of the Flourish HEC kit. Lastly, Los Angeles, California contributes to the advancement of knowledge through its central treatment-focused trial. These cities provide individuals with vulvodynia access to innovative clinical trials that aim to improve treatments for this challenging condition.

Which are the top treatments for vulvodynia being explored in clinical trials?

Vulvodynia, a condition characterized by chronic vulvar pain, is the subject of ongoing clinical trials exploring potential treatments. Two standout options include:

• High Intensity Laser Therapy (HILT): Currently being tested in one active trial and listed for the first time in 2022.
• BioNourish: This component of the Flourish HEC kit is also undergoing investigation in one active trial, with its initial listing also occurring in 2022. These innovative approaches hold promise for providing relief to individuals suffering from vulvodynia.

What are the most recent clinical trials for vulvodynia?

Recent clinical trials have been focusing on finding effective treatments for vulvodynia, a condition characterized by chronic pain in the vulvar area. One notable trial is investigating central treatment approaches specifically tailored to address this issue. Although still in Phase 2, the study holds promise for developing interventions that target the root causes of vulvodynia and alleviate symptoms. By prioritizing research efforts in this field, medical professionals strive to enhance understanding and improve outcomes for individuals living with vulvodynia.

What vulvodynia clinical trials were recently completed?

Several recent clinical trials have focused on addressing vulvodynia, a chronic pain condition affecting the vulva. Notably, a trial sponsored by the National Institute of Allergy and Infectious Diseases concluded in October 2021, evaluating potential treatments for this debilitating condition. Additionally, another trial led by a team from Mount Sinai Hospital was completed in September 2021, investigating novel approaches to managing vulvodynia symptoms. These studies highlight ongoing efforts to better understand and alleviate the distressing effects of vulvodynia, bringing hope to those affected by this often misunderstood disorder